Clincosm LogoSign in Get a demo

Leukemia, Lymphocytic, Chronic, B-Cell

Showing 26 - 50 of 55
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MabThera Subcutaneous Safety in Non-Hodgkin's Lymphoma or

Completed
  • Lymphoma, Non-Hodgkin
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Bucheon-si,, Korea, Republic of
  • +24 more
Jan 7, 2021

Malignant Tumor, Leukemia, Lymphocytic, Chronic, B-Cell, Lung Disease Chronic Trial in Seattle (Jumpstart Intervention)

Completed
  • Malignant Neoplasm
  • +9 more
  • Jumpstart Intervention
  • Seattle, Washington
  • +1 more
Nov 3, 2020

Leukemia, Lymphocytic, Chronic, B-Cell Trial in Duarte, Boston, Portland (BI 836826, Ibrutinib)

Completed
Has Results
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Duarte, California
  • +2 more
Sep 8, 2020

Leukemia, Lymphocytic, Chronic, B-Cell Trial in Belgium, France, Germany (BI 836826)

Completed
Has Results
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • BI 836826
  • Bruxelles, Belgium
  • +9 more
Aug 10, 2020

Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

Completed
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Lymphoma, Mantle-Cell
  • Ahmedabad, India
  • +7 more
Aug 5, 2020

Leukemia, Lymphocytic, Chronic, B-Cell Trial in Houston (INVAC-1)

Terminated
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • INVAC-1
  • Houston, Texas
    MD Anderson Cancer Center
Jul 6, 2020

Leukemia, Lymphocytic, Chronic, B-Cell Trial in Poland, Spain (Ibrutinib, OC: Ethinylestradiol (EE) 30 mcg and Levonorgestrel

Completed
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Krakow, Poland
  • +3 more
Dec 3, 2019

Lymphoma, Mantle-cell, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Hairy Cell Trial run by the NHLBI (ON01910 Na)

Completed
  • Lymphoma, Mantle-cell
  • +4 more
  • ON01910 Na
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 30, 2019

Leukemia, Lymphocytic, Chronic, B-Cell Trial in Tours (GA101, Ibrutinib, Cyclophosphamide)

Completed
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Tours, France
    Sponsor FILO
Feb 14, 2019

Leukemia, Lymphocytic, Chronic, B-Cell Trial in Spain (Cyclophosphamide, Fludarabine, Rituximab)

Completed
Has Results
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Vitoria, Alava, Spain
  • +32 more
Jul 27, 2018

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in Worldwide (Part 1 (Dose

Terminated
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +4 more
  • Part 1 (Dose Escalation): Duvortuxizumab
  • Part 2 (Dose Expansion): Duvortuxizumab
  • Detroit, Michigan
  • +19 more
Dec 19, 2018

Leukemia, Lymphocytic, Acute, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell Trial in Shenzhen (CART19 cell

Unknown status
  • Leukemia, Lymphocytic, Acute, B-Cell
  • +2 more
  • CART19 cell and auto-HSCT
  • Shenzhen, Guangdong, China
    Weihong Chen
Dec 5, 2018

Leukemia, Lymphocytic, Chronic, B-Cell Trial in Durham (Lenalidomide + Plerixafor (+ Rituximab))

Completed
Has Results
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Lenalidomide + Plerixafor (+ Rituximab)
  • Durham, North Carolina
    Duke University Medical Center
Jul 26, 2017

Leukemia, Lymphocytic, Chronic, B-Cell Trial (Venetoclax, BI 836826)

Withdrawn
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • (no location specified)
Jan 8, 2018

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial (Duvortuxizumab, Ibrutinib)

Withdrawn
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +3 more
  • (no location specified)
Nov 22, 2017

Leukemia, Lymphocytic, Chronic, B-Cell Trial in Huai'an, Xuzhou (CAR-T)

Unknown status
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • CAR-T
  • Huai'an, Jiangsu, China
  • +1 more
Aug 3, 2017

Haematology Score asTool for Predicting Tolerance to Treatment

Completed
  • Myelodysplastic Syndromes
  • +3 more
    • Oviedo, Asturias, Spain
    • +14 more
    Jul 24, 2017

    Leukemia, Myeloid, Acute, MDS, Lymphoma, Non-Hodgkin Trial in Saint Louis (Sargramostim, Plerixafor)

    Completed
    Has Results
    • Leukemia, Myeloid, Acute
    • +5 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    May 3, 2017

    Leukemia, Lymphocytic, Chronic, B-Cell Trial in Toronto (ruxolitinib, ibrutinib)

    Unknown status
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Toronto, Ontario, Canada
    • +1 more
    Mar 8, 2017

    Lymphoma, Large B-Cell, Diffuse, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma,Malignant Trial in Chongqing (CD19 or CD20 CAR

    Unknown status
    • Lymphoma, Large B-Cell, Diffuse
    • +2 more
    • CD19 or CD20 CAR T cells briging HSCT
    • Chongqing, Chongqing, China
      Southwest Hospital of Third Millitary Medical University
    Sep 6, 2016

    Leukemia, Lymphocytic, Chronic, B-Cell Trial in United States (Alemtuzumab plus Fludarabine)

    Completed
    Has Results
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Alemtuzumab plus Fludarabine
    • Birmingham, Alabama
    • +26 more
    Jul 27, 2016

    Leukemia, Lymphocytic, Chronic, B-Cell Trial in Marseille (Data collection)

    Recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Data collection
    • Marseille, Bouches-du Rhône, France
      Institut Paoli-Calmettes
    Aug 16, 2016

    Treatment of Chronic Lymphocytic Leukemia

    Unknown status
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • shRNA
    • (no location specified)
    May 11, 2016

    Leukemia, Lymphocytic, Chronic, B-Cell Trial (Ibrutinib combined with As2O3, ibrutinib)

    Unknown status
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • (no location specified)
    Apr 27, 2016

    Leukemia, Lymphocytic, Chronic, B-Cell Trial in Japan (alemtuzumab)

    Completed
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Nagoya, Aichi, Japan
    • +5 more
    Apr 29, 2015